TrueMark Investments LLC Has $5.40 Million Holdings in The Clorox Company (NYSE:CLX)

TrueMark Investments LLC increased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 8.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,702 shares of the company's stock after purchasing an additional 2,993 shares during the period. Clorox makes up 1.4% of TrueMark Investments LLC's portfolio, making the stock its 17th biggest position. TrueMark Investments LLC's holdings in Clorox were worth $5,404,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the company. Cambridge Investment Research Advisors Inc. lifted its stake in Clorox by 106.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 85,766 shares of the company's stock valued at $12,629,000 after acquiring an additional 44,246 shares in the last quarter. Synergy Asset Management LLC bought a new stake in Clorox in the 1st quarter valued at $350,000. Intact Investment Management Inc. boosted its stake in Clorox by 7,950.0% in the 1st quarter. Intact Investment Management Inc. now owns 32,200 shares of the company's stock valued at $4,741,000 after purchasing an additional 31,800 shares during the period. Stonegate Investment Group LLC lifted its position in shares of Clorox by 52.7% during the 1st quarter. Stonegate Investment Group LLC now owns 2,070 shares of the company's stock valued at $305,000 after acquiring an additional 714 shares during the period. Finally, PFG Investments LLC lifted its position in shares of Clorox by 13.2% during the 1st quarter. PFG Investments LLC now owns 4,154 shares of the company's stock valued at $612,000 after acquiring an additional 485 shares during the period. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Clorox stock traded up $1.56 during mid-day trading on Monday, reaching $122.33. The company had a trading volume of 1,687,291 shares, compared to its average volume of 1,364,125. The stock's 50-day simple moving average is $132.74 and its 200-day simple moving average is $146.30. The company has a market capitalization of $15.08 billion, a P/E ratio of 21.96, a P/E/G ratio of 2.73 and a beta of 0.54. The Clorox Company has a 1 year low of $120.33 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a net margin of 9.89% and a return on equity of 324.23%. The business's revenue was down 8.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.71 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Morgan Stanley decreased their price target on Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Evercore ISI set a $140.00 target price on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Barclays cut their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a report on Wednesday, May 7th. Wells Fargo & Company dropped their target price on Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Finally, JPMorgan Chase & Co. dropped their price target on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a report on Tuesday, May 6th. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of "Hold" and a consensus price target of $151.23.

Insider Activity

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The stock was bought at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director now owns 4,000 shares in the company, valued at $546,280. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.57% of the stock is owned by company insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.